Please sign in to follow a disease.
VR rollercoasters vs. beach meditations: which changes your blood more?
NCT ID NCT07042178
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how watching relaxing or stressful virtual reality (VR) content changes stress-related substances in the blood of 30 healthy adults. Participants watched a beach meditation or a rollercoaster ride for about 5 minutes, and blood was taken before and after. The goal was to see if different VR experiences affect blood markers like stress hormones and clotting factors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Aug 2025
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 18 and 45 years old; * Willing and able to provide written informed consent. Exclusion Criteria: * A history of motion- or cybersickness; * Fear of needles; * Any of the following haematological disorders: * Congenital or acquired haemophilia A; * Von Willebrand Disease. * Any of the following endocrinological disorders: * Thyroid disorders (e.g. hypo/hyperthyroidism); * Cushing syndrome; * Adrenal insufficiency; * Diabetes mellitus type 1 or 2; * Central or nephrogenic AVP deficiency. * A confirmed cardiac disorder; * All types of epilepsy; * Every form of medication, except for intermittent use of pain killers but not in the last week (e.g. paracetamol) and an intra-uterine device with or without contraceptive; * Pregnancy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Endocrinology are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Medical Centre Utrecht
Utrecht, 3584CX, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a glucose monitor boost diabetes education for newly diagnosed patients?
- Childhood head trauma may cause hidden hormone issues years later
- Can a simple questionnaire predict who will follow their treatment?
- Virtual reality goggles could replace some sedation during gut procedures
- Steroids before birth may alter Baby's blood counts
- New shot could help diabetics shed pounds on top of existing meds